• The Medolac Difference
    • Why Milk Banking
    • Safety & Quality
    • Data & Publications
    • Breast Milk Donation
    • Frequently Asked Questions
  • Products & Pipeline
    • Co-op Donor Milk
    • Can you keep a secret?
    • Biorepository
  • Hospital Account Registration
    • Terms & Conditions
  • About
    • Message from CEO
    • Corporate Responsibility
    • Press Releases
    • Leadership >
      • Executive Team
      • Board of Directors
    • Contact

CEO blog

We Don't Believe In Taking Chances

1/27/2016

0 Comments

 

By: Elena Medo, CEO Medolac

Although Co-op Donor Milk, processed by Medolac Laboratories, is simply 100% human milk with nothing added, we have raised the bar when it comes to our safety standard for donor screening as well as raw milk testing compared to traditional milk banking practices.  Our partnership with the American Red Cross National Testing Laboratories has enabled us to utilize a more robust donor screening program and we have expanded donor blood testing to include screening for West Nile Virus and Chagas Disease (T. Cruzi) in addition to HIV 1 and 2, HTLV I and II, HBV, HCV and syphilis.  Our testing is repeated twice in the first year of donor participation.  We have also raised the bar for donor milk testing and continue to expand our testing as we examine and report on a variety of areas including microbiological and viral safety, environmental toxins, drugs of abuse, heat stable toxins, prescription drugs and ethanol.

We are an evidence based company and as such, we believe that it is necessary to have a comprehensive understanding of the risks inherent in human milk banking in order to take decisive and effective action to lower or mitigate such risks.  Such a risk case has not been done.  While human milk is truly miraculous, it is not magic.  If not handled properly, it can become contaminated with high levels of bacteria and associated toxins plus spores that cannot be removed using any heat treatment and could result in serious illness.  We will be sharing our research with the medical community to promote a better understanding of the potential risks and benefits of donor milk.   After years of studying this, we believe that anything short of commercial sterility is unacceptable in the neonatal intensive care unit.

0 Comments



Leave a Reply.

    Author

    Elena Medo
    CEO and Founder
    ​Medolac Laboratories

    View my profile on LinkedIn

    Archives

    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    October 2015
    September 2015

    Categories

    All

    RSS Feed

CONTACT US:
Phone: 1(866) 599-7740
Email:
info@medolac.com
Medolac Laboratories, Copyright 2016
Co-op Donor Milk is processed at the world's largest human milk bank. We offer the most affordable donor milk solutions for the Neonatal Intensive Care Unit, discharged infants who need donor milk for home use, and more. Explore the donor milk options Medolac has to offer today, offered by the world's leading milk bank for innovative human milk based nutritional products. With no shortages, and improved safety and quality Co-op Donor Milk is changing lives around the world. Learn more about milk banking, and donor milk by exploring our website or contacting us today.
  • The Medolac Difference
    • Why Milk Banking
    • Safety & Quality
    • Data & Publications
    • Breast Milk Donation
    • Frequently Asked Questions
  • Products & Pipeline
    • Co-op Donor Milk
    • Can you keep a secret?
    • Biorepository
  • Hospital Account Registration
    • Terms & Conditions
  • About
    • Message from CEO
    • Corporate Responsibility
    • Press Releases
    • Leadership >
      • Executive Team
      • Board of Directors
    • Contact
✕